Brief: Selvita Receives Significant Order From European Biopharmaceutical Company Worth Up to €5 Million
03/09/2026 16:08
BRIEF-Selvita Receives Significant Order From European Biopharmaceutical Company Worth Up to €5 Million Sept 3 (Reuters) - Selvita SA SLV1.WA:
SELVITA RECEIVES SIGNIFICANT ORDER FROM EUROPEAN BIOPHARMACEUTICAL COMPANY
TOTAL ORDER VALUE UP TO EUR 5 MILLION
ORDER COVERS CONTINUATION OF INTEGRATED DRUG DISCOVERY PROJECT BY COMPANY FOR CLIENT
Source text: ID:nEM8tLps7a
Further company coverage: SLV1.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Selvita SA
See all newsBrief: Selvita Units Selvita Services And Pozlab Sign Merger Plan
Brief: Selvita Appoints Rafal Chwast As CEO
Brief: Selvita Q2 Net Loss At 3.0 Mln Zlotys
Brief: Selvita Receives Significant Order From European Biopharmaceutical Company Worth Up to €5 Million
Brief: Selvita Q1 Net Loss At 5.5 Million Zlotys